Rapport Therapeutics, Inc.

RAPPCIK 0002012593 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 10, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0153Δ-0.000589% similar+464/-494 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 7, 2026no items parsed Apr 21, 2026no items parsed Mar 10, 2026no items parsed Jan 7, 2026no items parsed Jan 7, 2026no items parsed

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.05pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Rapport Therapeutics, Inc.

Name	Roles	Filings
Bredt David	Officer	16
Ceesay Abraham	OfficerDirector	9
Gault Cheryl	Officer	8
Yeleswaram Krishnaswamy	Officer	8
Trv Gp V, LLC	10% Owner	5

Showing 1-5 of 28

Per pagePage 1 of 6Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Rapport Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Bredt David	21	10%	-31.6%	-21.1%	+6.7%	-120.8%
2	Healy James	17	0%	-21.1%	-19.5%	-19.5%	-24.9%
3	Ceesay Abraham	24	25%	-12.0%	-15.7%	+3.3%	-43.0%
4	Gault Cheryl	3	67%	-6.4%	+1.5%	+4.2%	-24.8%

All filings

72 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 28, 2026	Third Rock Ventures V, L.P. 10% Owner	SSale	18,572	$40.047	$743,753
May 13, 2026	Third Rock Ventures V, L.P. 10% Owner	SSale	133,618	$40.244	$5,377,323
May 11, 2026	Third Rock Ventures V, L.P. 10% Owner	SSale	271,495	$40.121	$10,892,651
Apr 21, 2026	Yeleswaram Krishnaswamy Chief Development Officer	SSale	20,225	$39.9923	$808,844
Apr 21, 2026	Third Rock Ventures V, L.P. 10% Owner	SSale	426,005	$40.317	$17,175,244

Showing 1-5 of 72

Per pagePage 1 of 15Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value